Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Dec. 29, 2012	Dec. 31, 2011
Operating activities:
Net income	$ 1,363,709	$ 1,124,968
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	318,231	217,755
Provision for losses on accounts receivable	(18,846)	9,000
Increase in cash value of life insurance	(15,559)	(87,780)
Deferred compensation	(14,202)	(13,150)
Stock compensation expense	14,264	18,066
Changes in operating assets and liabilities:
Accounts receivable	344,036	(497,769)
Inventories	2,374,880	2,498,982
Prepaid expenses and other assets	(270,566)	213,202
Accounts payable and accrued expenses	(646,781)	(876,098)
Net cash provided by operating activities	3,449,166	2,607,176
Investing activities:
Acquisition of M.C. Healthcare		(7,897,335)
Proceeds from sale of securities available for sale		4,000,000
Purchases of property and equipment	(39,079)	(336,856)
Payments for other assets	(50,355)	(39,670)
Net cash used for investing activities	(89,434)	(4,273,861)
Financing activities:
Proceeds of long-term debt		7,000,000
Repayment of long-term debt		(6,000,000)
Dividends paid	(3,288,070)	(307,522)
Proceeds from exercise of options for common stock	19,955
Net cash (used for) provided by financing activities	(3,268,115)	692,478
Effect of exchange rates on cash	(80,519)	(7,929)
Increase (Decrease) in cash and cash equivalents	11,098	(982,136)
Cash and cash equivalents at beginning of period	2,665,302	2,124,406
Cash and cash equivalents at end of period	$ 2,676,400	$ 1,142,270